Grohskopf, L.A., et al., Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018–19 Influenza Season. MMWR Recomm Rep, 2018. 67(3): p. 1–20.
Committee opinion no. 608: influenza vaccination during pregnancy. Obstet Gynecol, 2014. 124(3): p. 648–51.
Farquharson, R.G., E. Jauniaux, and N. Exalto, Updated and revised nomenclature for description of early pregnancy events. Human Reproduction, 2005. 20(11): p. 3008–11.
Donahue, J.G., et al., Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12. Vaccine, 2017. 35(40): p. 5314–22.
Chambers, C.D., R. Xu, and A.A. Mitchell, Commentary on: "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12". Vaccine, 2017. 35(40): p. 5323–4.
Steinhoff, M.C., et al., Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis, 2017. 17(9): p. 981–9.
Chambers, C.D., et al., Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine, 2013. 31(44): p. 5026–32.
Chambers, C.D., et al., Safety of the 2010–11, 2011–12, 2012–13, and 2013–14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS. Vaccine, 2016. 34(37): p. 4443–9.
Chavant, F., et al., The PREGVAXGRIP Study: a Cohort Study to Assess Foetal and Neonatal Consequences of In Utero Exposure to Vaccination Against A(H1N1)v2009 Influenza. Drug Safety, 2013. 36(6): p. 455–65.
Huang, W.T., et al., Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan. Vaccine, 2014. 32(48): p. 6463–8.
Ludvigsson, J.F., et al., Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. Bmj, 2015. 351: p. h5585.
Ma, F., et al., Prospective cohort study of the safety of an influenza A(H1N1) vaccine in pregnant Chinese women. Clin Vaccine Immunol, 2014. 21(9): p. 1282–7.
Oppermann, M., et al., A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine, 2012. 30(30): p. 4445–52.
Pasternak, B., et al., Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ : British Medical Journal, 2012. 344.
Tavares, F., et al., Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: A prospective cohort study. Vaccine, 2011. 29(37): p. 6358–65.
Irving, S.A., et al., Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion. Obstetrics & Gynecology, 2013. 121(1): p. 159–65.
Sammon, C.J., et al., Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD. PLoS One, 2012. 7(12): p. e51734.
Heikkinen, T., et al., Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol, 2012. 207(3): p. 177.e1–8.
de Vries, L., et al., Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands. Birth Defects Res A Clin Mol Teratol, 2014. 100(10): p. 731–8.
McMillan, M., et al., Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine, 2015. 33(18): p. 2108–17.
Bednarczyk, R.A., D. Adjaye-Gbewonyo, and S.B. Omer, Safety of influenza immunization during pregnancy for the fetus and the neonate. American Journal of Obstetrics & Gynecology, 2012. 207(3): p. S38–S46.
Bratton, K.N., et al., Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: a systematic review and meta-analysis. Clin Infect Dis, 2015. 60(5): p. e11–9.
Eaton, A., et al., Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009–2010. Vaccine, 2017.
Angelo, M.G., et al., Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme. Pharmacoepidemiol Drug Saf, 2014. 23(5): p. 466–79.
Baril, L., et al., Risk of spontaneous abortion and other pregnancy outcomes in 15–25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Vaccine, 2015. 33(48): p. 6884–91.
Bonde, U., et al., Is HPV vaccination in pregnancy safe? Hum Vaccin Immunother, 2016. 12(8): p. 1960–4.
Dana, A., et al., Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine. Obstet Gynecol, 2009. 114(6): p. 1170–8.
Forinash, A.B., et al., Safety of the HPV Bivalent and Quadrivalent Vaccines During Pregnancy. Ann Pharmacother, 2011. 45(2): p. 258–62.
Garland, S.M., et al., Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Obstet Gynecol, 2009. 114(6): p. 1179–88.
Goss, M.A., et al., Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. Vaccine, 2015. 33(29): p. 3422–8.
Panagiotou, O.A., et al., Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. Bmj, 2015. 351: p. h4358.
Scheller, N.M., et al., Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes. N Engl J Med, 2017. 376(13): p. 1223–33.
Wacholder, S., et al., Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. Bmj, 2010. 340: p. c712.
Vichnin, M., et al., An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Pediatr Infect Dis J, 2015. 34(9): p. 983–91.
Badilla, X., et al., Fetal risk associated with rubella vaccination during pregnancy. Pediatr Infect Dis J, 2007. 26(9): p. 830–5.
Sato, H.K., et al., Rubella vaccination of unknowingly pregnant women: the Sao Paulo experience, 2001. J Infect Dis, 2011. 204 Suppl 2: p. S737–44.
Tookey, P.A., et al., Rubella vaccination in pregnancy. CDR (Lond Engl Rev), 1991. 1(8): p. R86–8.
Makris, M.C., et al., Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf, 2012. 35(1): 1–14.
Badell, M.L., et al., Risks Associated With Smallpox Vaccination in Pregnancy: A Systematic Review and Meta-analysis. Obstet Gynecol, 2015. 125(6): p. 1439–51.
Mosby, L.G., S.A. Rasmussen, and D.J. Jamieson, 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. American Journal of Obstetrics and Gynecology, 2011. 205(1): p. 10–18.
Rasmussen, S.A., D.J. Jamieson, and T.M. Uyeki, Effects of influenza on pregnant women and infants. American Journal of Obstetrics and Gynecology, 2012. 207(3, Supplement): p. S3–S8.
Calleja-Agius, J., et al., Pro- and antiinflammatory cytokines in threatened miscarriages. American Journal of Obstetrics and Gynecology, 2011. 205(1): p. 83.e8–83.e16.
Lissauer, D., et al., Profile of maternal CD4 T-cell effector function during normal pregnancy and in women with a history of recurrent miscarriage. Clinical Science, 2014. 126(5): p. 347–54.
Christiansen, O.B., H.S. Nielsen, and A.M. Kolte, Inflammation and miscarriage. Seminars in Fetal and Neonatal Medicine, 2006. 11(5): p. 302–8.
Christian, L.M., et al., Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine, 2011. 29(48): p. 8982–7.
Christian, L.M., et al., Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination. Vaccine, 2015. 33(29): p. 3360–6.
Yang, J., et al., CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination. International Immunology, 2013. 25(8): p. 447–57.
Schmidt, T., et al., CD4+T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. European Journal of Immunology, 2012. 42(7): p. 1755–66.
Belongia, E.A., et al., Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines, 2017. 16(7): p. 1–14.
Feng, J., et al., Antibody quantity versus quality after influenza vaccination. Vaccine, 2009. 27(45): p. 6358–62.
Sasaki, S., et al., Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One, 2008. 3(8): p. e2975.